nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia
|
Song, Juanjuan |
|
|
103 |
2 |
p. 463-473 |
artikel |
2 |
Absence of blood donors’ anti-SARS-CoV-2 antibodies in pre-storage leukoreduced red blood cell units indicates no role of passive immunity for blood recipients
|
Casale, Maddalena |
|
|
103 |
2 |
p. 623-629 |
artikel |
3 |
A comparative study of platelet storage lesion in platelet-rich plasma under cryopreservation
|
Dang, E. |
|
|
103 |
2 |
p. 631-643 |
artikel |
4 |
Analysis of PROC mutations and clinical features in 22 unrelated families with inherited protein C deficiency
|
Xu, Fei |
|
|
103 |
2 |
p. 645-652 |
artikel |
5 |
Analysis of PROS1 mutations and clinical characteristics in three Chinese families with hereditary protein S deficiency
|
Xu, Fei |
|
|
103 |
2 |
p. 653-662 |
artikel |
6 |
A prospective, multicenter, observational study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in Japan
|
Horigome, Yuichi |
|
|
103 |
2 |
p. 475-488 |
artikel |
7 |
BRCA2 germline mutation in familial leukaemia with familial breast cancer: a case report
|
Wang, Jing |
|
|
103 |
2 |
p. 685-687 |
artikel |
8 |
CEAC (oral semustine, etoposide, cytarabine and cyclophosphamide) vs BEAM (carmustine, etoposide, cytarabine, and melphalan) conditioning regimen of autologous stem cell transplantation for diffuse large B-cell lymphoma: a post-hoc, propensity score-matched, cohort study in Chinese patients
|
Wang, Tao |
|
|
103 |
2 |
p. 575-582 |
artikel |
9 |
Clinical characteristics of hepatitis-associated aplastic anemia in children
|
Fu, Lingling |
|
|
103 |
2 |
p. 397-404 |
artikel |
10 |
Cold agglutinin–induced acrocyanosis without hemolytic anemia
|
Kitamura, Wataru |
|
|
103 |
2 |
p. 681-683 |
artikel |
11 |
Comment on: Association between anemia and depression: results from NHANES 2005–2018 and Mendelian randomization analyses
|
Si, Tianyu |
|
|
103 |
2 |
p. 689-691 |
artikel |
12 |
Comment on: Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis
|
Li, Na |
|
|
103 |
2 |
p. 693-694 |
artikel |
13 |
Correction to: Correlation between IPSET‑t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience
|
Tosoni, Luca |
|
|
103 |
2 |
p. 449 |
artikel |
14 |
Correction to: Molecular characteristics of hereditary red blood cell membrane disorders in Thailand: a multi‑center registry
|
Songdej, Duantida |
|
|
103 |
2 |
p. 395 |
artikel |
15 |
Correlation between IPSET-t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience
|
Tosoni, Luca |
|
|
103 |
2 |
p. 443-448 |
artikel |
16 |
Detection and quantification of JAK2V617F copy number by droplet digital PCR versus real-time PCR
|
Wu, Sanyun |
|
|
103 |
2 |
p. 421-426 |
artikel |
17 |
Differential expression of adhesion molecules in sickle cell anemia and gut microbiome effect
|
Delgadinho, Mariana |
|
|
103 |
2 |
p. 409-419 |
artikel |
18 |
Distinct FDG PET/CT avidity among newly diagnosed intravascular large B-cell lymphoma patients: a descriptive observational study
|
Zhao, Danqing |
|
|
103 |
2 |
p. 545-552 |
artikel |
19 |
Epigenetically dysregulated NOTCH-Delta-HES signaling cascade can serve as a subtype classifier for acute lymphoblastic leukemia
|
Hussan, Syeda Saliah |
|
|
103 |
2 |
p. 511-523 |
artikel |
20 |
Factors associated with inpatient mortality during daunorubicin and cytarabine induction in adults with acute myeloid leukemia—a national inpatient sample analysis
|
Savani, Saloni |
|
|
103 |
2 |
p. 663-665 |
artikel |
21 |
Feasibility of allogeneic hematopoietic stem cell transplantation in advanced age
|
Fernandez-Luis, Sara |
|
|
103 |
2 |
p. 583-591 |
artikel |
22 |
25-Hydroxy vitamin D deficiency is an inferior predictor of peripheral T-cell lymphomas
|
Shen, Hao-Rui |
|
|
103 |
2 |
p. 565-574 |
artikel |
23 |
Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study
|
Brusosa, Marc |
|
|
103 |
2 |
p. 609-621 |
artikel |
24 |
Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience
|
Sobas, Marta |
|
|
103 |
2 |
p. 451-461 |
artikel |
25 |
In-depth molecular analysis of lymphomas with lymphoplasmacytic differentiation may provide more precise diagnosis and rational treatment allocation
|
Brunner, Andrea |
|
|
103 |
2 |
p. 553-563 |
artikel |
26 |
Leukemic non-nodal cyclin D1- and SOX11-negative mantle cell lymphoma with CCND3::IGH rearrangement
|
Tan, Lennart |
|
|
103 |
2 |
p. 667-669 |
artikel |
27 |
Liver failure after treatment with inotuzumab and polychemotherapy including PEG-asparaginase in a patient with relapsed Philadelphia chromosome–negative acute lymphoblastic leukemia
|
Fischer, Daniel |
|
|
103 |
2 |
p. 489-498 |
artikel |
28 |
Madrid Newborn Sickle Cell Disease Cohort: clinical outcomes, stroke prevention and survival
|
García-Morin, Marina |
|
|
103 |
2 |
p. 373-383 |
artikel |
29 |
Molecular characteristics of hereditary red blood cell membrane disorders in Thailand: a multi-center registry
|
Songdej, Duantida |
|
|
103 |
2 |
p. 385-393 |
artikel |
30 |
Myeloablative or reduced-intensity/non-myeloablative hematopoietic cell transplantation for Philadelphia-positive acute lymphoblastic leukemia in adults older than 40 years old — a secondary analysis of a CIBMTR database
|
de Oliveira Fernandes Junior, Irtis |
|
|
103 |
2 |
p. 603-607 |
artikel |
31 |
Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine
|
Lucijanic, Marko |
|
|
103 |
2 |
p. 671-672 |
artikel |
32 |
Non-viral pathogens of infectious diarrhoea post-allogeneic stem cell transplantation are associated with graft-versus-host disease
|
Rees, Matthew J. |
|
|
103 |
2 |
p. 593-602 |
artikel |
33 |
Olverembatinib combined with blinatumomab in treating T315I-mutated Philadelphia chromosome–positive acute lymphoblastic leukemia: two-case report
|
Fan, Shengxuan |
|
|
103 |
2 |
p. 525-532 |
artikel |
34 |
Pulmonary Erdheim-Chester disease successfully treated with vemurafenib
|
Shen, Kai-ni |
|
|
103 |
2 |
p. 673-675 |
artikel |
35 |
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes
|
Barbui, Tiziano |
|
|
103 |
2 |
p. 437-442 |
artikel |
36 |
Safe utilization of ruxolitinib in simultaneous primary myelofibrosis and warm autoimmune hemolytic anemia
|
Pope, Victor |
|
|
103 |
2 |
p. 677-679 |
artikel |
37 |
Successful treatment with oseltamivir phosphate in children with ITP who failed first-line therapy: a case series report
|
Liu, Li-ya |
|
|
103 |
2 |
p. 405-408 |
artikel |
38 |
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib
|
Mulas, Olga |
|
|
103 |
2 |
p. 427-436 |
artikel |
39 |
USF2 promotes autophagy and proliferation in chronic lymphocytic leukemia by inhibiting STUB1-induced NFAT5 ubiquitination
|
Chen, Beili |
|
|
103 |
2 |
p. 533-544 |
artikel |
40 |
Zanubrutinib-lenalidomide-rituximab (ZR2) in unfit diffuse large B-cell lymphoma: efficient and tolerant
|
Wang, Yawen |
|
|
103 |
2 |
p. 499-510 |
artikel |